Non-coding RNAs are involved in tumor cell death and affect tumorigenesis, progression, and treatment: a systematic review

Front Cell Dev Biol. 2024 Feb 28:12:1284934. doi: 10.3389/fcell.2024.1284934. eCollection 2024.

Abstract

Cell death is ubiquitous during development and throughout life and is a genetically determined active and ordered process that plays a crucial role in regulating homeostasis. Cell death includes regulated cell death and non-programmed cell death, and the common types of regulatory cell death are necrosis, apoptosis, necroptosis, autophagy, ferroptosis, and pyroptosis. Apoptosis, Necrosis and necroptosis are more common than autophagy, ferroptosis and pyroptosis among cell death. Non-coding RNAs are regulatory RNA molecules that do not encode proteins and include mainly microRNAs, long non-coding RNAs, and circular RNAs. Non-coding RNAs can act as oncogenes and tumor suppressor genes, with significant effects on tumor occurrence and development, and they can also regulate tumor cell autophagy, ferroptosis, and pyroptosis at the transcriptional or post-transcriptional level. This paper reviews the recent research progress on the effects of the non-coding RNAs involved in autophagy, ferroptosis, and pyroptosis on tumorigenesis, tumor development, and treatment, and looks forward to the future direction of this field, which will help to elucidate the molecular mechanisms of tumorigenesis and tumor development, as well as provide a new vision for the treatment of tumors.

Keywords: autophagy, ferroptosis; non-coding RNAs; pyroptosis; treatment; tumor progression; tumorigenesis.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Guangdong Provincial Medical Science and Technology Research Fund Projects (Nos A2023216, A2022524, and A2020304), Basic and Applied Basic Research Foundation of Guangdong Province (No. 2022A1515220217), Science and Technology Program of Guangzhou (Nos 202201010840, 202201010810, 202102080532, 202002030032, 202002020023, and 20211A011116), Health Commission Program of Guangzhou (Nos 20212A010025 and 20201A010085), Science and Technology Project of Panyu, Guangzhou (Nos 2022-Z04-009, 2022-Z04-090, 2022-Z04-072, 2021-Z04-053, 2020-Z04-052, 2020-Z04-026, and 2019-Z04-02), and Scientific Research Project of Guangzhou Panyu Central Hospital (Nos PY-2023-001, PY-2023-002, PY-2023-003, PY-2023-004, PY-2023-005, 2022Y002; 2021Y004, and 2021Y002).